Rambam Health Care Campus
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1938-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.rambam.org.il
Clinical Trials
462
Active:2
Completed:186
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:7
Phase 2:26
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (275 trials with phase data)• Click on a phase to view related trials
Not Applicable
183 (66.5%)Phase 4
38 (13.8%)Phase 2
26 (9.5%)Phase 3
16 (5.8%)Phase 1
7 (2.5%)Early Phase 1
5 (1.8%)Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
Phase 2
Recruiting
- Conditions
- Fibromyalgia
- Interventions
- Drug: Cannabis Oil (5% THC/5% CBD)Drug: Sham Cannabis Oil
- First Posted Date
- 2025-04-27
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 150
- Registration Number
- NCT06946940
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Montreal Cognitive Assessment Index Following MRI Guided Focused Ultrasound Thalamotomy
Completed
- Conditions
- Essential Tremor
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 142
- Registration Number
- NCT06941285
Artificial Intelligence as a Decision Making Tool in Neurology
Active, not recruiting
- Conditions
- Clinical Decision-makingMedical ReportingNeurological Diseases or ConditionsEmergency Department Visit
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 1000
- Registration Number
- NCT06902675
- Locations
- 🇮🇱
Rambam healthcare campus, Haifa, Israel
Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis
Phase 4
Not yet recruiting
- Conditions
- Myasthenia Gravis Crisis
- Interventions
- Drug: IV efgartigimod
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 16
- Registration Number
- NCT06688253
- Locations
- 🇮🇱
Rambam- Department of Neurology, Haifa, Israel
Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.
Not Applicable
Active, not recruiting
- Conditions
- Respiratory Distress SyndromePrematurityNon Invasive Ventilation
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 45
- Registration Number
- NCT06622902
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
- Prev
- 1
- 2
- 3
- 4
- 5
- 93
- Next
News
No news found